Animal-Free Protein Platforms Will Transform Sustainable Biotech Industries

Published
12 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$9.00
91.0% undervalued intrinsic discount
15 Aug
US$0.81
Loading
1Y
-38.6%
7D
-1.2%

Author's Valuation

US$9.0

91.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 21%

Shared on24 Apr 25
Fair value Decreased 17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25